Breast Cancer Clinical Trials

Showing 1101-1120 of 4,817 trials

Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors

NCT01450020

This randomized clinical trial studies peer navigator education in improving survivorship care in African American breast cancer survivors. An educational intervention involving peer groups may help to improve the well-being and quality of life (QOL) in breast cancer survivors

Breast Cancer

City of Hope Medical Center145 participantsStarted Jun 2012

Duarte, California, United States

COMPLETEDPhase 2

Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer

NCT06355024

This is a Phase II, open-label, single-arm study evaluating the efficacy and safety of combined treatment of Inosine with chemotherapy in mTNBC (triple negative breast cancer) patients who progressed during previous chemotherapy.

Triple-negative Breast Cancer

Fudan University10 participantsStarted May 2024

Shanghai, Shanghai Municipality, China

Active Not RecruitingPhase 1

T-Cell Therapy for Advanced Breast Cancer

NCT02792114

The purpose of this study is to test the safety of different doses of specially prepared T cells collected from the blood. The investigators want to find a safe dose of these modified T cells for patients who have metastatic HER2-negative breast cancer.

Breast CancerMetastatic HER2-negative Breast

Memorial Sloan Kettering Cancer Center186 participantsStarted Jun 2016

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +4 more locations

Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors

Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer

T-Cell Therapy for Advanced Breast Cancer

Related Searches

Non-inferiority Study of Contrast-enhanced Digital Mammography (CEDM) vs Magnetic Resonance Imaging (MRI) in Terms of Diagnostic Accuracy in Patients Undergoing Preoperative Staging of Established Invasive Breast Cancer

Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer

Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

Mechanisms of Response and Resistance to Innovative Treatments in Patients With Locally Advanced or Metastatic Breast Cancer

Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab

BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer

Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

Uptake of Genetic Counseling Among African American Women

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer

POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer

Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations